SR

Seelath Ramees Jawhar

Active Director Managing Director DIN 11407866
DIN 11407866 First appointment Dec 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Seelath Ramees Jawhar

Data last updated:

Seelath Ramees Jawhar is a Managing Director at Curay Pharma Private Limited (since 2025).

DIN 11407866
Primary Designation Managing Director
First Appointment 03 Dec 2025

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Curay Pharma Private Limited U46497KL2025PTC098851
Managing Director03 Dec 20252025Active

Directorship timeline

Open interactive timeline →
Curay Pharma Private Limited
Premium access

Shareholding and investment profile for Seelath Ramees Jawhar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Seelath Ramees Jawhar

Seelath Ramees Jawhar currently holds 1 directorship: Curay Pharma Private Limited (Managing Director, since 03 Dec 2025).

Seelath Ramees Jawhar was first appointed on 03 Dec 2025 as Managing Director at Curay Pharma Private Limited.

The current boards of Seelath Ramees Jawhar's companies include Abdul Nasar Kolambil (Curay Pharma Private Limited), Mohammed Kabeer Poola Kuzhiyil (Curay Pharma Private Limited), Rafeeq Mothirapeedika Abhoobaker Mohamed (Curay Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available